A new stability indicating RP-UPLC method for simultaneous estimation of Doravirine, Lamivudine and Tenofovir disoproxil fumarate in bulk and their combined pharmaceutical formulation

A new stability indicating RP-UPLC method for simultaneous estimation of Doravirine, Lamivudine and Tenofovir disoproxil fumarate in bulk and their combined pharmaceutical formulation

Abstract Background To establish a simple, sensitive, accurate, precise, efficient, economical RP-UPLC method for simultaneous estimation of Doravirine, Lamivudine and Tenofovir disoproxil fumarate in bulk and their combined pharmaceutical formulations. Optimization of Chromatographic separation was...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Swetha Addanki, B. Ramya Kuber
Format: article
Langue:EN
Publié: SpringerOpen 2021
Sujets:
Doravirine
Lamivudine
Tenofovir disoproxil fumarate
Method validation
Forced degradation
Reverse phase ultra-performance liquid chromatographic method
Therapeutics. Pharmacology
RM1-950
Pharmacy and materia medica
RS1-441
Accès en ligne:https://doaj.org/article/9aaa1830c1a94f64ad697aede88574c2
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/9aaa1830c1a94f64ad697aede88574c2

Documents similaires